India to Remain a Cost-Competitive Hub

13:54 PM | May 25, 2009 | Deepti Ramesh

Contract manufacturing of active pharmaceutical ingredients (APIs) and finished dosage drug forms will grow in India at 30%-40%/year until 2013, says a new report from Frost & Sullivan India (F&S;...